Celanese

Celanese Corp. engages in the provision of technology and specialty materials businesses. It operates through the following segments: Engineered Materials, Acetate Tow, Acetyl Chain and Other Activities. The Engineered Materials segment includes the engineered materials business, food ingredients business and certain strategic affiliates. The Acetate Tow segment serves consumer-driven applications and is a global producer and supplier of acetate tow and acetate flake used in filter products applications. The Acetyl Chain segment includes the integrated chain of intermediate chemistry, emulsion polymers and ethylene vinyl acetate (EVA) polymers businesses, based on similar products, production processes, classes of customers and selling and distribution practices as well as economic similarities over a normal business cycle. The Other Activities segment consists of corporate center costs, including administrative activities such as finance, information technology and human resource functions, interest income and expenses associated with financing activities. The company was founded by Camille Dreyfus and Henri Dreyfus in 1918 and is headquartered in Irving, TX.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Celanese reports robust Q4 performance, addresses challenges, eyes growth

Celanese's Q4 performance was strong, with a focus on debt reduction and strategic investments. Challenges in the M&M business are being addressed, while opportunities lie in market dynamics and operational enhancements. The company's clear Lake expansion project and cost-saving initiatives position it for future growth.

Celanese reports solid Q1 performance, eyes market recovery opportunities

Celanese's Q1 earnings call highlighted a strong performance with a focus on market recovery and controllable actions. The company faces challenges in slower demand growth but sees opportunities in market trends and synergies.

Celanese faces China demand challenges but anticipates debt reduction success

Celanese navigated challenges in China and the Acetyl Chain, with signs of price movement up despite lower demand. Sequential improvement is expected in 4Q through cost control and synergies. The company is focused on aggressively lowering debt and diversifying distribution channels for growth.

Celanese reports robust Q3 earnings, targets debt reduction and growth

Celanese's Q3 earnings call highlighted strong performance in key segments, with a focus on earnings growth, debt reduction, and market challenges. The company's strengths include flexibility, synergies, and cost optimization strategies, while facing challenges from demand uncertainties and pricing fluctuations. Opportunities for Celanese include strategic expansions, sustainability initiatives, and debt reduction goals for future growth.

Celanese projects strong 2024 performance with focus on synergies

Celanese is poised for strong performance in 2024 with a focus on cost efficiencies and operational synergies.
The company's strategic strengths lie in projected synergies, margin expansion, and deleveraging efforts.
Challenges include past volume losses and reliability issues, but opportunities exist in market growth and operational enhancements.
Overall, Celanese is strategically positioned to navigate market conditions and drive value creation.

Celanese resilient in Q1 amidst market disruptions and growth opportunities

Celanese navigated market disruptions to maintain strong financial performance.
Focus on synergies, controllable actions, and market conditions to meet guidance.
Opportunities lie in consumer confidence, Clear Lake expansion, and cost efficiencies.
Challenges include pricing pressure, market disruptions, and delayed startups in China.

Celanese projects growth in Q3 and Q4 amidst market challenges

Celanese anticipates stable market conditions and growth opportunities in Q3 and Q4 driven by synergy capture and productivity improvements.
Efforts to resolve acetyls force majeure and mitigate pricing pressures on raw materials are ongoing.
The company is focused on maximizing free cash flow efficiency, reducing debt, and adapting to market dynamics for sustained growth.
Evaluation of divestiture opportunities and maintaining a balanced approach in methanol integration are key strategic considerations.

Celanese disappoints in Q3, plans dividend cut for deleveraging

Celanese faces challenges from macroeconomic headwinds, prompting actions to support deleveraging and enhance profitability. The company's focus on cost reduction, synergies, and project pipeline acceleration aims to drive earnings growth. Clear Lake project and ongoing asset optimization present opportunities for value creation.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Celanese Corporation (NYSE: CE) has faced a series of downgrades and reduced price targets from prominent financial institutions, reflecting growing concerns about the company's performance in a challenging global environment. Most recently, on 5 September, analysts at Piper Sandler downgraded Celanese from Overweight to Neutral, lowering the price target from $180 to $150.

Celanese Corp stock price prediction: Will the stock keep on falling?

DALLAS--(BUSINESS WIRE)---- $CE--Celanese Corporation Lifts Force Majeure on Western Hemisphere Acetic Acid and VAM.

Celanese Corporation Lifts Force Majeure on Western Hemisphere Acetic Acid and VAM

Celanese is a global producer of specialty chemicals and material products that are involved in several end markets and for a wide range of applications globally. The company reported lower revenues and earnings per share in its recent Q2'24 results, with declines in both the Engineered Materials and Acetyl Chain businesses. Despite challenges, EBITDA grew 18% due to cost synergies, leading to margin expansion.

Celanese Corporation: Margin Expansion Story Doesn't Offset Leverage Risks

Robinhood

Essent Group

Five9

Lockheed Martin

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

This Robinhood Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Monday

Celanese Corporation (NYSE:CE ) Q2 2024 Earnings Conference Call August 2, 2024 11:00 AM ET Company Participants Bill Cunningham - VP of IR Lori Ryerkerk - Chairman of the Board and CEO Scott Richardson - COO Chuck Kyrish - CFO Conference Call Participants Josh Spector - UBS Mike Sison - Wells Fargo Mike Leithead - Barclays Jeff Zekauskas - JPMorgan Ghansham Panjabi - Baird Arun Viswanathan - RBC Capital Markets Vincent Andrews - Morgan Stanley Matthew Hettwer - Vertical Research Partners Aleksey Yefremov - KeyBanc Capital Markets David Begleiter - Deutsche Bank Hassan Ahmed - Alembic Global Salvator Tiano - Bank of America Laurence Alexander - Jefferies Patrick Cunningham - Citi John Roberts - Mizuho Securities John McNulty - BMO Capital Markets Operator Greetings and welcome to Celanese's Second Quarter 2024 Earnings Call and Webcast. [Operator Instructions].

Celanese Corporation (CE) Q2 2024 Earnings Call Transcript

The decline in net sales of Celanese (CE) in Q2 is a result of a decrease in pricing.

Celanese (CE) Q2 Earnings and Sales Fall Short of Estimates

Although the revenue and EPS for Celanese (CE) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Celanese (CE) Reports Q2 Earnings: What Key Metrics Have to Say

Celanese (CE) came out with quarterly earnings of $2.38 per share, missing the Zacks Consensus Estimate of $2.80 per share. This compares to earnings of $2.17 per share a year ago.

Celanese (CE) Lags Q2 Earnings and Revenue Estimates

DALLAS--(BUSINESS WIRE)--Celanese Corporation Reports Second Quarter Earnings.

Celanese Corporation Reports Second Quarter Earnings

e.l.f. Beauty

Pinterest

Fortune recently reported that mergers and acquisitions (M&A) activity is up 17% worldwide through the first half of 2024. Of this activity, 90% of the largest deals so far year-to-date were U.S. targets.

M&A Stock Picks: 3 Acquisition Targets to Buy Now

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Celanese (CE), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2024.

Unveiling Celanese (CE) Q2 Outlook: Wall Street Estimates for Key Metrics

Air Products and Chemicals

Axalta Coating Systems

Chemours

Chemical companies are expected to have benefited from demand recovery across key end markets and moderated de-stocking activities. Let's see how APD, CE, CC and AXTA are poised ahead of their earnings releases.

Can These 4 Chemical Stocks Hit Targets This Earnings Season?

Celanese's (CE) investment in high-return organic projects, cost-cutting initiatives, and acquisition synergies are likely to have contributed to its Q2 performance amid demand and pricing headwinds.

Celanese (CE) to Report Q2 Earnings: What's in the Offing?

Celanese (CE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Celanese (CE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Celanese (CE) benefits from its productivity measures, investments in organic projects, expansion actions and strategic acquisitions amid headwinds from demand softness and pricing pressures.

Here's Why You Should Hold Onto Celanese (CE) Stock for Now

Alcoa

Intrepid Potash

As the global economy faces numerous headwinds, including fluctuating commodity prices and economic uncertainty, certain materials stocks are increasingly risky investments. Here are three materials stocks to sell to reduce exposure to this market cyclicality.

3 Materials Stocks to Sell in July Before They Crash & Burn

DALLAS--(BUSINESS WIRE)--Celanese to Hold Second Quarter Earnings Conference Call on August 2, 2024.

Celanese to Hold Second Quarter Earnings Conference Call on August 2, 2024

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Here's Why Celanese (CE) is a Strong Value Stock

PPG Industries

Soft end-market demand and customer de-stocking mar the prospects of the Zacks Chemicals Specialty industry. PPG, CE and AXTA are set to gain from strategic actions to navigate the ongoing challenges.

3 Chemical Specialty Stocks to Escape Industry Headwinds

National Vision Hlds

DULUTH, Ga.--(BUSINESS WIRE)--National Vision, Inc., one of the nation's largest optical retailers, hosted more than 1,000 optometrists across two weekends for its Annual Continuing Education (CE) Symposium in Phoenix June 1-4 and in Orlando June 8-11. The conference was designed to empower doctors through education and camaraderie, giving them the tools they need to foster successful optometry careers. “We are committed to empowering our network of optometrists to lead and innovate in their fi.

National Vision Gathers More Than 1,000 Optometrists at Annual Continuing Education Symposium

While Celanese (CE) faces headwinds from soft demand and pricing, it benefits from productivity measures, investments in organic projects and strategic acquisitions.

Celanese (CE) Gains on Cost Actions Amid Demand & Pricing Woes

Celanese (CE) declares force majeure for acetic acid and VAM, expects a 15-20% production impact in the second quarter and takes costly measures to minimize customer impact.

Celanese (CE) Declares Force Majeure Due to Supply Disruptions

Bristol-Myers

General Motors

KeyCorp

Paramount Global

Sirius XM Holdings Inc

The Oracle of Omaha is by far the most well-known long-term investor we have alive today, and if you are a newbie, looking into Warren Buffett stocks to sell is a good way to weed out the bad stocks from your portfolio. I believe Berkshire Hathaway (NYSE: BRK-A , NYSE: BRK-B ) alone makes for a pretty good starter portfolio, as it acts like an exchange-traded fund with solid growth.

7 Stocks Warren Buffett Has Sold in the Past Year (and You Should Too)

DALLAS--(BUSINESS WIRE)--Celanese Corporation Declares Force Majeure on Western Hemisphere Acetic Acid and VAM.

Celanese Corporation Declares Force Majeure on Western Hemisphere Acetic Acid and VAM

While Celanese (CE) faces challenges from demand softness and pricing pressures, it benefits from strategic acquisitions, expansion moves and productivity measures.

News for Celanese Stock (CE)